Wing Lee : Circulars - (1) Proposed Granting of General Mandates to Repurchase Shares and to Issue New Shares of the Company; (2) Proposed Re-election of the Retiring Director of the Company; and (3) Notice of the Annual General Meeting of the Company

If you are in any doubt as to any aspect of this circular or as to the action to be taken, you should consult a licensed securities dealer, or registered institution in securities, a bank manager, solicitor, professional accountant or other professional adviser. If you have sold or transferred all your shares in Mega Medical Technology Limited (the "Company"), you should at once hand this circular, together with the enclosed form of proxy, to the purchaser or transferee or to the bank, licensed securities dealer, registered institution in securities or other agent through whom the sale was effected for transmission to the purchaser or transferee.

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this circular, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this circular.

MEGA MEDICAL TECHNOLOGY LIMITED

美 加 醫 學 科 技 有 限 公 司

(Incorporated in Bermuda with limited liability)

(Stock Code: 876)

1. PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES OF THE COMPANY;
2. PROPOSED RE-ELECTION OF THE RETIRING DIRECTOR OF THE COMPANY; AND
3. NOTICE OF THE ANNUAL GENERAL MEETING OF THE COMPANY

A notice convening an annual general meeting (the "2017 AGM") of the Company to be held at Unit 1307, 13/F, C C Wu Building, 302-308 Hennessy Road, Wan Chai, Hong Kong on Friday, 19 May 2017 at 11:00 a.m. is set out on pages 19 to 23 of this circular. A form of proxy for use at the 2017 AGM is enclosed with this circular. Such form of proxy is also published on the websites of The Stock Exchange of Hong Kong Limited (www.hkexnews.hk) and the Company (http://www.megamedicaltech.com).

Whether or not you are able to attend the 2017 AGM, please complete and sign the accompanying form of proxy in accordance with the instructions printed thereon and return it to the Company's Branch Share Registrar and Transfer Office in Hong Kong, Tricor Tengis Limited, at Level 22, Hopewell Centre, 183 Queen's Road East, Hong Kong as soon as possible but in any event not less than 48 hours before the time appointed for the holding of the 2017 AGM or any adjournment thereof. Completion and return of the form of proxy will not preclude the shareholders of the Company from attending and voting in person at the meeting if they so wish and in such event, the form of proxy shall be deemed to be revoked.

18 April 2017

Page

Definitions ............................................................................................................................ 1 Letter from the Board

1. Introduction....................................................................................................... 3

2. Proposed granting of the Repurchase and Issuance Mandates .......................... 4

3. Proposed re-election of the retiring Director..................................................... 5

4. 2017 AGM and proxy arrangement .................................................................. 12

5. Recommendation .............................................................................................. 13

6. General information .......................................................................................... 13

7. Responsibility statement .................................................................................. 14

Appendix - Explanatory statement on the Repurchase Mandate.............................. 15 Notice of 2017 AGM............................................................................................................ 19

In this circular, unless the context otherwise requires, the following expressions shall have the following meanings:

"2017 AGM" an annual general meeting of the Company to be held at Unit 1307, 13/F, C C Wu Building, 302-308 Hennessy Road, Wan Chai, Hong Kong on Friday, 19 May 2017 at 11:00 a.m., to consider and, if appropriate, to approve the resolutions contained in the notice of the meeting which is set out on pages 19 to 23 of this circular, or any adjournment thereof;

"Board" the board of Directors;

"Bye-laws" the Bye-laws of the Company currently in force;

"CG Code" Corporate Governance Code set out in Appendix 14 to the Listing Rules;

"Company" Mega Medical Technology Limited 美加醫學科技有限公 司, a company incorporated in Bermuda with limited liability, the shares of which are listed on the Main Board of the Stock Exchange;

"Director(s)" the director(s) of the Company;

"Group" the Company and its subsidiaries from time to time;

"HK$" Hong Kong dollars, the lawful currency of Hong Kong;

"Hong Kong" the Hong Kong Special Administrative Region of the PRC; "Issuance Mandate" as defined in paragraph 2(b) of the Letter from the Board; "Latest Practicable Date" 11 April 2017, being the latest practicable date prior to the

printing of this circular for ascertaining certain information in this circular;

"Listing Rules" the Rules Governing the Listing of Securities on the Stock Exchange;

"PRC" the People's Republic of China;

"Repurchase Mandate" as defined in paragraph 2(a) of the Letter from the Board; "SFO" the Securities and Futures Ordinance, Chapter 571 of the Laws

of Hong Kong;

"Share(s)" ordinary share(s) of HK$0.00125 each in the capital of the Company or if there has been a subsequent subdivision, consolidation, reclassification or reconstruction of the share capital of the Company, shares forming part of the ordinary equity share capital of the Company;

"Shareholder(s)" holder(s) of Share(s);

"Stock Exchange" The Stock Exchange of Hong Kong Limited;

"Takeovers Code" the Code on Takeovers and Mergers issued by the Securities

and Futures Commission of Hong Kong;

"%" per cent.